Heart Antigen

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 8709 Experts worldwide ranked by ideXlab platform

Bellur S Prabhakar - One of the best experts on this subject based on the ideXlab platform.

  • Molecular cloning of a Heart Antigen that cross-reacts with a neutralizing antibody to Coxsackievirus B4.
    European heart journal, 1991
    Co-Authors: Kirk W Beisel, Javaraiah Srinivasappa, Bellur S Prabhakar
    Abstract:

    A panel of coxsackievirus B4 (CVB4) neutralizing monoclonal antibodies was tested against a panel of normal mouse tissues. One mAb, 356-1, reacted specifically with murine Heart tissue. Examination of the reactivity of 356-1 with CVB4 polypeptides using Western immunoblotting revealed that 356-1 binds to the VP-1 capsid protein. Immunohistochemical studies revealed an A band pattern of staining of the Heart by this antibody. Western immunoblotting of sequential differential extracts of Heart showed that 356-1 predominantly reacted with the murine cardiac myosin heavy chain. A rather weak cross-reaction was found with actin. These observations were confirmed by the binding of 356-1 to purified cardiac myosin and actin. This antibody showed a higher affinity for murine cardiac muscle myosin than for skeletal muscle myosin. The monoclonal antibody 356-1 was then used to screen a lambda gt11 CD1 mouse Heart cDNA expression library. Forty-eight positive plaques were obtained, 14 of which reacted strongly with the antibody and were selected for additional studies. In 13/14 clones, inserts were amplified using the polymerase chain reaction (PCR). The PCR products ranged in size from approximately 150 to 1400 bp. Northern hybridization using these inserts demonstrated that 10/13 recognized a approximately 6.5 kb message in mouse Heart total RNA and not in liver total RNA. These amplified inserts were sequenced and were found to contain sequences which encode approximately 1/3 of the amino-terminal end of light meromyosin. By comparison with known sequences of rat alpha and beta cardiac myosin heavy chains, we were able to identify sequences specific for alpha chain as potential cross-reactive autoAntigenic epitope.(ABSTRACT TRUNCATED AT 250 WORDS)

  • molecular cloning of a Heart Antigen that cross reacts with a neutralizing antibody to coxsackievirus b4
    European Heart Journal, 1991
    Co-Authors: Kirk W Beisel, Javaraiah Srinivasappa, Bellur S Prabhakar
    Abstract:

    A panel of coxsackievirus B4 (CVB4) neutralizing monoclonal antibodies was tested against a panel of normal mouse tissues. One mAb, 356-1, reacted specifically with murine Heart tissue. Examination of the reactivity of 356-1 with CVB4 polypeptides using Western immunoblotting revealed that 356-1 binds to the VP-1 capsid protein. Immunohistochemical studies revealed an A band pattern of staining of the Heart by this antibody. Western immunoblotting of sequential differential extracts of Heart showed that 356-1 predominantly reacted with the murine cardiac myosin heavy chain. A rather weak cross-reaction was found with actin. These observations were confirmed by the binding of 356-1 to purified cardiac myosin and actin. This antibody showed a higher affinity for murine cardiac muscle myosin than for skeletal muscle myosin. The monoclonal antibody 356-1 was then used to screen a Agt11 CD1 mouse Heart cDNA expression library. Forty-eight positive plaques were obtained, 14 of which reacted strongly with the antibody and were selected for additional studies. In 13/14 clones, inserts were amplified using the polymerase chain reaction (PCR). The PCR products ranged in size from ∼150 to 1400 bp. Northern hybridization using these inserts demonstrated that 10/13 recognized a ∼6·5 kb message in mouse Heart total RNA and not in liver total RNA. These amplified inserts were sequenced and were found to contain sequences which encode ∼1/3 of the amino-terminal end of light meromyosin. By comparison with known sequences of rat alpha and beta cardiac myosin heavy chains, we were able to identify sequences specific for alpha chain as potential cross-reactive autoAntigenic epitope. This putative Antigenic site is located between amino-acid residues 1304 and 1647 of the alpha cardiac myosin encoded by the cDNAs. These studies imply that molecular mimicry is one mechanism by which autoimmunity might develop during CVB4 myocarditis.

Kirk W Beisel - One of the best experts on this subject based on the ideXlab platform.

  • Molecular cloning of a Heart Antigen that cross-reacts with a neutralizing antibody to Coxsackievirus B4.
    European heart journal, 1991
    Co-Authors: Kirk W Beisel, Javaraiah Srinivasappa, Bellur S Prabhakar
    Abstract:

    A panel of coxsackievirus B4 (CVB4) neutralizing monoclonal antibodies was tested against a panel of normal mouse tissues. One mAb, 356-1, reacted specifically with murine Heart tissue. Examination of the reactivity of 356-1 with CVB4 polypeptides using Western immunoblotting revealed that 356-1 binds to the VP-1 capsid protein. Immunohistochemical studies revealed an A band pattern of staining of the Heart by this antibody. Western immunoblotting of sequential differential extracts of Heart showed that 356-1 predominantly reacted with the murine cardiac myosin heavy chain. A rather weak cross-reaction was found with actin. These observations were confirmed by the binding of 356-1 to purified cardiac myosin and actin. This antibody showed a higher affinity for murine cardiac muscle myosin than for skeletal muscle myosin. The monoclonal antibody 356-1 was then used to screen a lambda gt11 CD1 mouse Heart cDNA expression library. Forty-eight positive plaques were obtained, 14 of which reacted strongly with the antibody and were selected for additional studies. In 13/14 clones, inserts were amplified using the polymerase chain reaction (PCR). The PCR products ranged in size from approximately 150 to 1400 bp. Northern hybridization using these inserts demonstrated that 10/13 recognized a approximately 6.5 kb message in mouse Heart total RNA and not in liver total RNA. These amplified inserts were sequenced and were found to contain sequences which encode approximately 1/3 of the amino-terminal end of light meromyosin. By comparison with known sequences of rat alpha and beta cardiac myosin heavy chains, we were able to identify sequences specific for alpha chain as potential cross-reactive autoAntigenic epitope.(ABSTRACT TRUNCATED AT 250 WORDS)

  • molecular cloning of a Heart Antigen that cross reacts with a neutralizing antibody to coxsackievirus b4
    European Heart Journal, 1991
    Co-Authors: Kirk W Beisel, Javaraiah Srinivasappa, Bellur S Prabhakar
    Abstract:

    A panel of coxsackievirus B4 (CVB4) neutralizing monoclonal antibodies was tested against a panel of normal mouse tissues. One mAb, 356-1, reacted specifically with murine Heart tissue. Examination of the reactivity of 356-1 with CVB4 polypeptides using Western immunoblotting revealed that 356-1 binds to the VP-1 capsid protein. Immunohistochemical studies revealed an A band pattern of staining of the Heart by this antibody. Western immunoblotting of sequential differential extracts of Heart showed that 356-1 predominantly reacted with the murine cardiac myosin heavy chain. A rather weak cross-reaction was found with actin. These observations were confirmed by the binding of 356-1 to purified cardiac myosin and actin. This antibody showed a higher affinity for murine cardiac muscle myosin than for skeletal muscle myosin. The monoclonal antibody 356-1 was then used to screen a Agt11 CD1 mouse Heart cDNA expression library. Forty-eight positive plaques were obtained, 14 of which reacted strongly with the antibody and were selected for additional studies. In 13/14 clones, inserts were amplified using the polymerase chain reaction (PCR). The PCR products ranged in size from ∼150 to 1400 bp. Northern hybridization using these inserts demonstrated that 10/13 recognized a ∼6·5 kb message in mouse Heart total RNA and not in liver total RNA. These amplified inserts were sequenced and were found to contain sequences which encode ∼1/3 of the amino-terminal end of light meromyosin. By comparison with known sequences of rat alpha and beta cardiac myosin heavy chains, we were able to identify sequences specific for alpha chain as potential cross-reactive autoAntigenic epitope. This putative Antigenic site is located between amino-acid residues 1304 and 1647 of the alpha cardiac myosin encoded by the cDNAs. These studies imply that molecular mimicry is one mechanism by which autoimmunity might develop during CVB4 myocarditis.

Javaraiah Srinivasappa - One of the best experts on this subject based on the ideXlab platform.

  • Molecular cloning of a Heart Antigen that cross-reacts with a neutralizing antibody to Coxsackievirus B4.
    European heart journal, 1991
    Co-Authors: Kirk W Beisel, Javaraiah Srinivasappa, Bellur S Prabhakar
    Abstract:

    A panel of coxsackievirus B4 (CVB4) neutralizing monoclonal antibodies was tested against a panel of normal mouse tissues. One mAb, 356-1, reacted specifically with murine Heart tissue. Examination of the reactivity of 356-1 with CVB4 polypeptides using Western immunoblotting revealed that 356-1 binds to the VP-1 capsid protein. Immunohistochemical studies revealed an A band pattern of staining of the Heart by this antibody. Western immunoblotting of sequential differential extracts of Heart showed that 356-1 predominantly reacted with the murine cardiac myosin heavy chain. A rather weak cross-reaction was found with actin. These observations were confirmed by the binding of 356-1 to purified cardiac myosin and actin. This antibody showed a higher affinity for murine cardiac muscle myosin than for skeletal muscle myosin. The monoclonal antibody 356-1 was then used to screen a lambda gt11 CD1 mouse Heart cDNA expression library. Forty-eight positive plaques were obtained, 14 of which reacted strongly with the antibody and were selected for additional studies. In 13/14 clones, inserts were amplified using the polymerase chain reaction (PCR). The PCR products ranged in size from approximately 150 to 1400 bp. Northern hybridization using these inserts demonstrated that 10/13 recognized a approximately 6.5 kb message in mouse Heart total RNA and not in liver total RNA. These amplified inserts were sequenced and were found to contain sequences which encode approximately 1/3 of the amino-terminal end of light meromyosin. By comparison with known sequences of rat alpha and beta cardiac myosin heavy chains, we were able to identify sequences specific for alpha chain as potential cross-reactive autoAntigenic epitope.(ABSTRACT TRUNCATED AT 250 WORDS)

  • molecular cloning of a Heart Antigen that cross reacts with a neutralizing antibody to coxsackievirus b4
    European Heart Journal, 1991
    Co-Authors: Kirk W Beisel, Javaraiah Srinivasappa, Bellur S Prabhakar
    Abstract:

    A panel of coxsackievirus B4 (CVB4) neutralizing monoclonal antibodies was tested against a panel of normal mouse tissues. One mAb, 356-1, reacted specifically with murine Heart tissue. Examination of the reactivity of 356-1 with CVB4 polypeptides using Western immunoblotting revealed that 356-1 binds to the VP-1 capsid protein. Immunohistochemical studies revealed an A band pattern of staining of the Heart by this antibody. Western immunoblotting of sequential differential extracts of Heart showed that 356-1 predominantly reacted with the murine cardiac myosin heavy chain. A rather weak cross-reaction was found with actin. These observations were confirmed by the binding of 356-1 to purified cardiac myosin and actin. This antibody showed a higher affinity for murine cardiac muscle myosin than for skeletal muscle myosin. The monoclonal antibody 356-1 was then used to screen a Agt11 CD1 mouse Heart cDNA expression library. Forty-eight positive plaques were obtained, 14 of which reacted strongly with the antibody and were selected for additional studies. In 13/14 clones, inserts were amplified using the polymerase chain reaction (PCR). The PCR products ranged in size from ∼150 to 1400 bp. Northern hybridization using these inserts demonstrated that 10/13 recognized a ∼6·5 kb message in mouse Heart total RNA and not in liver total RNA. These amplified inserts were sequenced and were found to contain sequences which encode ∼1/3 of the amino-terminal end of light meromyosin. By comparison with known sequences of rat alpha and beta cardiac myosin heavy chains, we were able to identify sequences specific for alpha chain as potential cross-reactive autoAntigenic epitope. This putative Antigenic site is located between amino-acid residues 1304 and 1647 of the alpha cardiac myosin encoded by the cDNAs. These studies imply that molecular mimicry is one mechanism by which autoimmunity might develop during CVB4 myocarditis.

Ricardo Ribeirodossantos - One of the best experts on this subject based on the ideXlab platform.

  • experimental chronic chagas disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial Antigens
    Journal of Autoimmunity, 2002
    Co-Authors: Lain Pontesdecarvalho, Claudia C Santana, Milena Botelho Pereira Soares, Geraldo Gileno De Sa Oliveira, Edecio Cunhaneto, Ricardo Ribeirodossantos
    Abstract:

    The protozoan Trypanosoma cruzi causes chronic Chagas’ disease myocarditis (CCDM) in infected mammals. The pathogenesis of CCDM, however, is still unclear. Indirect evidence for either parasite- or Heart-specific immune responses playing a pathogenic role is available. In this work, the participation of autoimmunity in the development of CCDM is demonstrated in mice in which immunological tolerance to Heart Antigens was induced or strengthened prior to their infection by T. cruzi. Tolerance was induced by Heart Antigen administration in the presence of complete Freund’s adjuvant and anti-CD4 antibodies. Tolerized mice developed less intense CCDM than control nontolerized animals that had received only anti-CD4 and adjuvant. This result confirms the important notion that tolerance to self, and in particular to Heart Antigens, may be reinforced/induced in normal animals, and raises the possibility that analogous interventions may prevent the development of CCDM in millions of T. cruzi-infected human beings.

Lain Pontesdecarvalho - One of the best experts on this subject based on the ideXlab platform.

  • experimental chronic chagas disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial Antigens
    Journal of Autoimmunity, 2002
    Co-Authors: Lain Pontesdecarvalho, Claudia C Santana, Milena Botelho Pereira Soares, Geraldo Gileno De Sa Oliveira, Edecio Cunhaneto, Ricardo Ribeirodossantos
    Abstract:

    The protozoan Trypanosoma cruzi causes chronic Chagas’ disease myocarditis (CCDM) in infected mammals. The pathogenesis of CCDM, however, is still unclear. Indirect evidence for either parasite- or Heart-specific immune responses playing a pathogenic role is available. In this work, the participation of autoimmunity in the development of CCDM is demonstrated in mice in which immunological tolerance to Heart Antigens was induced or strengthened prior to their infection by T. cruzi. Tolerance was induced by Heart Antigen administration in the presence of complete Freund’s adjuvant and anti-CD4 antibodies. Tolerized mice developed less intense CCDM than control nontolerized animals that had received only anti-CD4 and adjuvant. This result confirms the important notion that tolerance to self, and in particular to Heart Antigens, may be reinforced/induced in normal animals, and raises the possibility that analogous interventions may prevent the development of CCDM in millions of T. cruzi-infected human beings.